RxDoctor Payments Data

Ronald Fernando

Internal Medicine · Loma Linda, CANPI 1447355565

Payments from drug & device makers

$985,121in general payments, 2019–2025

Across 1,016 payments — averaging $969.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$338K
  • Bayer$267K
  • AstraZeneca$109K
  • Kowa Research Institute, Inc.$106K
  • Amgen$99K
  • AbbVie$67K
  • plus $97 from 1 others
$1,807in research payments, 2019–2025

Across 6 payments — averaging $301.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$2K

What the payments were for

  • Travel & lodging$1,47371%
  • Food & beverage$49224%
  • Education$975%

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS858$338,230
Bayer107$267,050
AstraZeneca6$108,515
Kowa Research Institute, Inc.25$105,665
Amgen15$98,858
AbbVie2$66,706
Novo Nordisk3$97

How this compares

$985,121 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in Loma Linda

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →